Infosys has signed an agreement to acquire Kaleidoscope Innovation, a full-spectrum product design, development and insights firm.
This deal will expand Infosys’ portfolio by combining cutting-edge technologies and experiences to revolutionise patient care, treatment, diagnostics and consumer health across the world.
Kaleidoscope Innovation has a diverse talent pool with extensive knowledge of design and engineering. It leverages a deep understanding of clinical environments, strong product development capabilities across domains, and a consultancy-style approach addressing human factors, product design, UI/UX design, research and insight, development and visualisation.
Among its clients are in-house labs, 3D design environments and customer experience centres.
Strong offerings and engineering capabilities
Kaleidoscope designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables. It also offers usability testing in support of regulatory submissions, including the delivery mechanism for aortic stents.
“Our clients will benefit from the combination of Kaleidoscope’s strong upstream offerings of product innovation and design, and Infosys’ stack of product engineering, validation and commercialisation services at a global scale,” said Ravi Kumar, President of Infosys.
According to Matt Kornau, CEO and Co-Founder of Kaleidoscope Innovation, the partnership will allow his company to scale quickly and bring expanded offerings in AI, analytics, and digital infrastructure to its clients.